Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?

Por Nappi, Rossella E, Merki-Feld, Gabriele S, Terreno, Erica, Pellegrinelli, Alice, Viana, Michele
Publicado em 2013

Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days

Por Merki-Feld, Gabriele S, Imthurn, Bruno, Langner, Ronald, Seifert, Burkhardt, Gantenbein, Andreas R
Publicado no J Headache Pain (2015)

Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users

Por Merki-Feld, Gabriele S., Epple, Gina, Caveng, Nina, Imthurn, Bruno, Seifert, Burkhardt, Sandor, Peter, Gantenbein, Andreas R.
Publicado no J Headache Pain (2017)

Awareness of headache and of national headache society activities among primary care physicians – a qualitative study

Por Gantenbein, Andreas R, Jäggi, Christian, Sturzenegger, Mathias, Gobbi, Claudio, Merki-Feld, Gabriele S, Emmenegger, Mark J, Taub, Ethan, Sándor, Peter S
Publicado em 2013

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contracept...

Por Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Sandset, Per Morten, Martelletti, Paolo
Publicado no J Headache Pain (2017)